Stay updated on Oral QLT091001 in LCA/RP Due to RPE65/LRAT Mutations Clinical Trial

Sign up to get notified when there's something new on the Oral QLT091001 in LCA/RP Due to RPE65/LRAT Mutations Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Oral QLT091001 in LCA/RP Due to RPE65/LRAT Mutations Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    No content additions or deletions were observed; the screenshots appear to show only cosmetic/UI layout differences.
    Difference
    0.1%
    Check dated 2026-03-29T00:35:27.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.3 to v3.5.0 on the page. No study details or eligibility information appear to be changed.
    Difference
    0.1%
    Check dated 2026-03-21T18:49:21.000Z thumbnail image
  4. Check
    23 days ago
    No Change Detected
  5. Check
    30 days ago
    Change Detected
    Summary
    - Revision updated from v3.4.2 to v3.4.3 in the page header/footer.
    Difference
    0.2%
    Check dated 2026-03-07T04:48:14.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    A non-essential overlay appears on the study details page, partially obscuring content but not altering core information or navigation.
    Difference
    0.1%
    Check dated 2026-02-28T01:31:27.000Z thumbnail image
  7. Check
    44 days ago
    Change Detected
    Summary
    No additions or deletions were detected; the page content appears unchanged.
    Difference
    0.1%
    Check dated 2026-02-20T21:21:37.000Z thumbnail image
  8. Check
    52 days ago
    Change Detected
    Summary
    Revision updated from v3.4.1 to v3.4.2; no other user-facing content changes detected. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-02-13T17:16:56.000Z thumbnail image

Stay in the know with updates to Oral QLT091001 in LCA/RP Due to RPE65/LRAT Mutations Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Oral QLT091001 in LCA/RP Due to RPE65/LRAT Mutations Clinical Trial page.